| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2022 | SRI INTERNATIONAL | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025 | SAN MATEO | USA | Cancer Biology Research | 000 | 3 | 8/28/2023 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $300,630 ) |
| 2022 | 2022 | SRI INTERNATIONAL | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025 | SAN MATEO | USA | Cancer Biology Research | 000 | 3 | 3/30/2022 | NON-COMPETING CONTINUATION | $300,630 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2020 | SRI INTERNATIONAL | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025 | SAN MATEO | USA | Cancer Biology Research | 000 | 2 | 3/16/2021 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $259,999 ) |
| 2020 | 2020 | SRI INTERNATIONAL | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025 | SAN MATEO | USA | Cancer Biology Research | 000 | 2 | 3/31/2020 | NON-COMPETING CONTINUATION | $259,999 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $257,409 ) |
| 2019 | 2019 | SRI INTERNATIONAL | 333 RAVENSWOOD AVE | MENLO PARK | CA | 94025 | SAN MATEO | USA | Cancer Biology Research | 000 | 1 | 4/4/2019 | NEW | $257,409 |
|
|